Study of Antithrombotic Treatment After IntraCerebral Haemorrhage

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 134 participants.

Also called NCT03186729

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03186729
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark, Norway, Sweden (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03186729. Randomized; single masking; primary purpose prevention. Start 2018-07-01 (actual); primary completion 2024-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
Acronym
STATICH
Condition
Cerebral Hemorrhage
Condition
Intracranial Hemorrhages
Condition
Anticoagulant-Induced Bleeding
Condition
Secondary Prevention
Intervention (Drug)
Antithrombotic Agent
Lead sponsor
Oslo University Hospital (class: other)

Record details

Record id
cardio:ct-nct03186729
Content hash
5fae05cd0022c9ae9e0f004ea469fb93aeae0a575cc3f24a97a5cf45307cd20b